Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Immunome Stock Skyrocketed Today


Shares of Immunome (NASDAQ:IMNM) soared on Thursday after the biotech announced the discovery of antibodies that could neutralize multiple coronavirus variants. 

By the close of trading, Immunome's stock price was up 75% after rising as much as 187% earlier in the day.

Immunome said it isolated "potent" antibodies that are potentially capable of neutralizing several variants of SARS-CoV-2, the virus that causes COVID-19. These strains include the South African variant, according to the company.

Continue reading


Source Fool.com


Comments